CBX5, CBX1, and CBX3 (HP1α, β , and γ respectively) play an evolutionarily conserved role in the formation and maintenance of heterochromatin. In addition, CBX5, CBX1, and CBX3 may also participate in transcriptional regulation of genes. Recently, CBX3 binding to the bodies of a subset of genes has been observed in human and murine cells.
Introduction
Once thought of as static components of heterochromatin, heterochromatin protein 1 family members (HP1s -CBX5, CBX1, and CBX3) are now known to function in a myriad of cellular processes including DNA repair, gene regulation, and telomere function (Hediger and Gasser, 2006; Kwon and Workman, 2008; Lomberk et al., 2006; Maison and Almouzni, 2004) . Su(var)205 (HP1a), HP1b, and HP1c were first characterized as suppressors of position effect variegation (PEV) in Drosophila, and along with H3K9 methylation were regarded as a hallmark of heterochromatin or repressed/silenced regions of the genome (Dillon, 2004; Huisinga et al., 2006; Lomberk et al., 2006) . More recently, CBX5, 1, and 3 have been assigned roles in repression of transcription at euchromatic genes (Hediger and Gasser, 2006; Hiragami and Festenstein, 2005; Kwon and Workman, 2008) . CBX proteins interact with and are recruited to specific loci by repressor proteins such as Retinoblastoma (Rb1) (Nielsen et al., 2001 ), IKZF1 (Ikaros) (Brown et al., 1997) , and TRIM28 (KAP1/TIFβ) (Ryan et al., 1999; Schultz et al., 2002) . CBX1 has been implicated in silencing of POU5F1 during early myogenesis (Feldman et al., 2006) . CBX3 has been linked to silencing at E2F-and MYC-responsive genes in G 0 cells (Ogawa et al., 2002) and the repression of the progestin responsive MMTV promoter in breast cancer cells (Vicent et al., 2006) . In conjunction with SUV39H1, CBX3 is also responsible for chromatin-mediated repression of the HIV-1 gene (du Chene et al., 2007) . Most recently, CBX3 recruitment, along with DNA and histone methylation, has been implicated in PIAS1 mediated FOXP3 repression in T-cell differentiation (Liu et al., 2010) . Biochemical studies have shed light on potential mechanisms of action for CBX5, CBX1, and CBX3 in this context (Smallwood et al., 2008; Smallwood et al., 2007) .
In recent years evidence has accumulated to implicate HP1 proteins in transcriptional activation. In Drosophila, cytological and genome-wide location studies Cold Spring Harbor Laboratory Press on October 27, 2017 -Published by genome.cshlp.org Downloaded from demonstrated that Su(var)205 binds to large domains in pericentric regions, repeat dense regions, transposable elements, and the entire X chromosome in male flies (de Wit et al., 2005 (de Wit et al., , 2007 Fanti et al., 2003; Greil et al., 2003) . In addition, Su(var)205 associated with exon-dense active genes on chromosome arms (de Wit et al., 2005 (de Wit et al., , 2007 Greil et al., 2003) . Su(var) 205 was shown to be necessary for transcription of heterochromatin associated genes (de Wit et al., 2007) . Su (var) 205 was also found to positively regulate transcript levels in euchromatin, most notably at the Hsp70 heat shock puff loci (Cryderman et al., 2005; Piacentini et al., 2003) . Most recently, CBX5 has been found associated with the promoters of genes with stalled RNA polymerase II (Yin et al., 2011) . In contrast, a separate study demonstrated that active genes bound by Su(var)205 have a lower expression level than unbound genes suggesting a negative role in transcription for Su(var) 205 (de Wit et al., 2005) . HP1c was also mapped to ~150 targets in active euchromatin (Greil et al., 2003) . It has also been suggested that HP1c appears can colocalize with poised Ser-5 phosphorylated RNA polymerase II (POLR2A) (Font-Burgada et al., 2008) . More recently, it was demonstrated that HP1c plays a role in recruitment of the FACT histone chaperone complex to active regions of the Drosophila genome functioning to link RNAP II and FACT (Kwon et al., 2010) .
In murine cells, CBX3 was found localized to the coding regions of several genes (Vakoc et al., 2005) . In addition, a switch has been observed from CBX3 binding at active genes to CBX5 and/or CBX1 binding inactive genes in human cells (Mateescu et al., 2008; Smallwood et al., 2007) . This suggests distinct and complementary roles for different members of this family of proteins. However, low resolution studies in mouse and humans suggests that CBX5, 1, and 3 may have similar overlapping binding profiles (Vogel et al., 2006) . It was previously shown that concurrent over-expression of CBX5, 1, and 3 in ECR-293 cells resulted in up-regulation of four genes, although it was not determined if these were direct effects (Hwang and Worman, 2002) . In addition, CBX3
Cold Spring Harbor Laboratory Press on October 27, 2017 -Published by genome.cshlp.org Downloaded from has been implicated in alternative splicing for a small subset of genes (Saint-Andre et al., 2011) . To date, the exact nature and mechanism by which heterochromatin protein 1 family members influence gene regulation remains unclear. Genome wide knowledge of specific gene targets would be an invaluable tool for understanding the mechanism of CBX3 gene regulation.
In the current study, we comprehensively determined CBX3 binding sites in the human genome, with the use of genome-wide location analysis, to gain a clearer picture of CBX3 action in gene regulation. We demonstrated that CBX3 localizes to the gene body of active genes in multiple cell lines and its binding positively correlates with gene activity. Loss of CBX3 results in a decrease in transcript level of a specific subset of target genes. Surprisingly, CBX3 is enriched at exonic sequences, and loss of CBX3 binding led to an increase in unspliced transcripts of its target genes. Loss of CBX3 also diminished the recruitment of splicing factors to gene bodies, consistent with the observed splicing defects. Thus, CBX3 appears to promote optimal co-transcriptional RNA processing through recruitment of the splicing machinery. Taken together, this study brings to light a novel role for the heterochromatin protein CBX3 in gene regulation, providing a functional link between transcription, chromatin, and RNA processing.
Results
Genome-wide localization of CBX3 to the gene body of active genes CBX3 was previously found in the gene body of a few active mammalian genes (Smallwood et al., 2007; Vakoc et al., 2005) . To get a clearer picture of CBX3 localization on a genome wide basis we performed ChIP-chip and ChIP-seq analysis in the human colorectal carcinoma cell line HCT116 . Two biological replicates of CBX3 IPs were analyzed by ChIP-seq and the results correlated well. In Cold Spring Harbor Laboratory Press on October 27, 2017 -Published by genome.cshlp.org Downloaded from addition, two independent biological replicates were used for ChIP-chip analysis with the Nimblegen and ENCODE platforms, all analyses yielded the same results. We found CBX3 binding was commonly confined within the transcribed gene body, but was also found spanning larger chromosomal regions encompassing one or more genes ( Figure   S1A ). In fact, analysis revealed that genome wide 89% of CBX3 occupied sequences are intragenic ( Figure 1A ). To determine if CBX3 binding correlates with gene activity, we grouped HCT116 genes into three tiers by expression. Enrichment of CBX3 binding was then calculated for a region encompassing 10 kb upstream of the transcription start site (TSS) and 10 kb down-stream of the 3' end. The top third expressed genes were enriched for CBX3 binding, whereas the bottom third unexpressed genes were not bound, with enrichment peaking at the 3' end of the gene body and then tapering off ( Figure 1B) . We also performed ChIP-chip analysis with two other cell types, K562
(erythroid) and MDA-MB-231 (breast), using Nimblegen HD2 genome-wide tiling arrays.
We found 7996 and 6241 CBX3-bound targets in K562 and MDA-MB-231 cells, respectively, compared to 8336 targets in HCT116 cells ( Figure 1C ). CBX3 binding was likewise correlated with gene expression levels in K562 and MDA-MB231 demonstrating this is general phenomenon ( Figure 1D ). For example, TIMP3, which has been implicated in breast cancer progression, was only expressed in MDA-MB-231 cells where it is bound by CBX3 ( Figure S1B ). In fact, over 90% of CBX3 targets for all cell types tested are expressed in the corresponding cells. Our data expand upon an initial observation, demonstrating that CBX3 localization to the body of active genes is a genome wide phenomenon. We therefore hypothesized that CBX3 is playing a functional role in gene regulation.
Dynamic Recruitment of CBX3
The experiments described above demonstrate that CBX3 is present in the gene body of active genes in unstimulated cells. However, it is not clear whether CBX3 is Figure S1C and data not shown). Next, we performed ChIP-seq analysis on TNF treated HCT116 cells and found that CBX3 was specifically and significantly recruited to many TNF-responsive genes (increased CBX3 binding was seen at 336 of 523 upregulated transcripts). Representative browser shots showing CBX3 occupancy at the IL8 and IRF1 loci, before or after TNF treatment, are shown ( Figure 1E ).
CBX3 interacts with elongating forms of RNA polymerase II
It was previously reported that RNA polymerase II could be coimmunoprecipitated from nuclear extract (NE) with CBX3 (Vakoc et al., 2005) . Indeed, CBX3 enrichment to gene bodies has been shown to be abrogated by treatment with the P-TEFb inhibitor DRB, which prevents RNA polymerase II elongation on active genes ( (Vakoc et al., 2005) , and J. Espinosa unpublished data). We performed coimmunoprecipitation assays using HeLa extracts and antibodies against CBX3. The results demonstrate that CBX3 interacts with the phosphorylated forms of RNA polymerase II ( Figure S1D ). This result suggests that CBX3 localization to active genes could, at least in part, be mediated by its association with the elongating form of RNA polymerase II. However, we also note that CBX3 is not present at all active genes, Cold Spring Harbor Laboratory Press on October 27, 2017 -Published by genome.cshlp.org Downloaded from suggesting that additional factors may affect CBX3 recruitment. Since CBX3 is known to bind to H3K9me2/3 via its chromodomain, we first asked whether this could also be the mechanism for its localization to gene bodies. However, we were not able to detect significant H3K9me2/3 at CBX3 target genes (data not shown). This is in agreement with HP1 and Su(var)3-9 localizing together at pericentric regions but independently at many other regions in Drosophila (Greil et al., 2003) . Next, we tested the possibility that CBX3 could be binding to or stabilized by the H3K36me3 modification, since CBX3 binding was strongly correlated with histone H3K36me3 enrichment in multiple cell types (data not shown). Biotinylated histone H3 tail peptides with K9me3, K36me3, or no modification were incubated with purified CBX3 ( Figure S1E ). As expected, CBX3 binds with high affinity to H3K9me3 peptides. However, no binding to the H3K36me3 modified peptide was detected.
CBX3 positively regulates transcript levels of its target genes
The data presented thus far suggests that CBX3 is recruited to genes upon activation, and could therefore be playing a role in gene regulation. However, it is unclear if CBX3 is acting to increase or decrease transcriptional output at its target loci.
To address this issue, we utilized an HCT116 cell line stably expressing a CBX3 specific shRNA construct (KD HCT116). CBX3 knockdown was validated by RT-qPCR and western blot analyses ( Figure S2A ). In all subsequent experiments the data presented as KD HCT116 cells is from analysis of clone #10 (clone #8 was also analyzed with similar results to clone #10, data not shown). Gene expression levels in WT and KD HCT116 cells were analyzed by Affymetrix exon arrays and RNA-seq, yielding comparable results. To determine to effect of CBX3 depletion on transcription we calculated expression of all genes in WT and KD HCT116 cells using the RNA-seq data set. Genes were grouped as those either bound or unbound by CBX3 in WT cells and then expression profiles of these gene groups compared in WT and KD cells. HP1γ bound genes are expressed at much higher levels than unbound targets, red and blue lines versus green and black lines ( Figure 2A ). Notably, there was a subset of genes unbound by CBX3 but still significantly expressed, these will be discussed later. Loss of CBX3 caused only mild transcriptional defects for a subset of genes. This suggests that the primary function of CBX3 binding to gene bodies may not be to directly regulate transcription levels per se. We therefore considered the possibility that CBX3 was influencing multiple facets of gene regulation.
CBX3 preferentially associates with exons in multi-exonic genes
Further analysis of CBX3 targets revealed that the bound genes were significantly longer than unbound genes (27227 bp versus 14161 bp, P < 4.77 E-283, Wilcoxon rank sum test) ( Figure 3A ). Additionally, CBX3 bound genes have a median exon number of ten whereas unbound genes have a median of five (p-value 1 E-300, Wilcoxon rank sun test) ( Figure 3B ). Next we calculated CBX3 occupancy at genes grouped by exon number, from one to 21+. CBX3 binding clearly favors multi-exon genes over single-exon genes ( Figure 3C and S4A). In addition, we calculated expression levels of genes grouped by exon number ( Figure 3D and S4A). Overlay of these two graphs revealed that CBX3 binding correlated with expression level of genes, for the most part, when grouped by exon number. Interestingly, in contrast to all other groups, single-exon genes were highly expressed despite a lack of CBX3 enrichment ( Figure S4A ). These data suggest that expression of longer, multi-exon genes is more dependent on HP1γ binding than that of single exon genes. In support of this idea, the mean exon number for the group of expressed unbound genes, mentioned in Figure 2A , is one. Next we created a heatmap of average CBX3 enrichment at the 5' of exons (and -/+ 2.5kb up and down-stream) ranked from low (black bar), to middle (green bar), and to high (red bar) expression. We observed that CBX3 is enriched at exon boundaries ( Figure 3E ). In addition, we plotted CBX3 enrichment (tag counts per kilo base) at exons versus introns for all genes and those with high, medium, or low CBX3 binding ( Figure   S4B ). While CBX3 binds to introns it is clearly enriched in exons. Increased CBX3 enrichment is correlated with increased exon expression levels ( Figure 3E and 3F).
Collectively, these data suggest that CBX3 could be playing a role in RNA processing.
Recently, CBX3 has been implicated in the regulation of alternative splicing with CBX3 enriched at alternatively spliced exons of CD44 (Saint-Andre et al., 2011) . In contrast, CBX3 is evenly recruited to CD44 in HCT116 cells and there was no change in splicing of this gene between WT and KD cells (data not shown). To further investigate, we calculated CBX3 enrichment (RPKM value) for exons included in mature transcripts (spliced in) versus those not included (spliced out) in HCT116 cells. We observed that CBX3 enrichment is not significantly different for alternatively spliced or constitutive exons ( Figure S4C ). Additionally, loss of CBX3 did not decrease inclusion of 219 alternatively spliced exons examined. Intriguingly, we found that loss of CBX3 results in an increased inclusion of exons usually spliced out ( Figure 3F ). The preference for exon rich genes and enrichment at exons coupled with increased exon inclusion in the absence of CBX3 led us to consider the possibility that CBX3 could be regulating RNA processing generally but not alternative splicing specifically in our system.
Loss of function of CBX3 causes a disruption in splicing of target genes
To test whether CBX3 indeed participates in RNA processing, we first examined the IL8 gene. We designed primer pairs spanning each exon-intron junction as well as one exon-exon junction. Exon-intron spanning primers will amplify unspliced transcripts whereas exon-exon spanning primers only measure spliced transcripts. This approach allowed us to compare the expression level of spliced and unspliced IL8 mRNAs in WT and CBX3 KD HCT116 cells. We calculated the ratio of intron (exon-intron junction) to exon (exon-exon junction) expression across the IL8 gene for WT and KD cells ( Figure   4A , left). In addition, fold change of intron expression, or level of unspliced transcript, in WT to KD cells was analyzed ( Figure 4A right) . We detected a significant increase in intron inclusion in KD HCT116 cells at every splice junction across the IL8 gene (P < 0.05, t-test). In fact, loss of CBX3 leads to a 2-5 fold increase in unspliced IL8 transcripts in the KD HCT116 cells.
To ascertain if this was a common effect of CBX3 loss we analyzed intron inclusion in several additional TNF-responsive genes including IL1A, EHD1, and LTB ( Figure 4B and S5A). As observed for IL8, loss of CBX3 resulted in an increase in unspliced transcripts for all CBX3 target genes tested. The correlation between loss of CBX3 and increase in intron inclusion was also seen for the CBX3-responsive gene HOXA9 in unstimulated cells ( Figure 4C ). However, no increase in unspliced transcripts was observed for genes not bound by CBX3, such as NFKB1 and ZC3H12C ( Figure 4D and S5B), these genes show no disruption of RNA processing. Therefore, the RNA processing defect we observe correlates with a decrease in CBX3 binding.
Loss of CBX3 results in global RNA processing defect
To further investigate the role of HP1γ in RNA processing, we performed genome wide analysis of both poly-A and non-poly-A transcript levels from WT and KD HCT116 cells. Total RNA was isolated from WT and KD HCT116 cells and subjected to highthroughput sequencing analysis after depletion of ribosomal RNA. Exonic and intronic expression was measured using this procedure for all UCSC genes with detectable transcription (RPKM ≥ 0.5, which is approximately the median RPKM of the samples).
We quantified the fraction of intronic expression as intron RPKM / exon RPKM for each gene and found 1037 transcripts that display a marked increase in intronic expression in the KD compared to WT cells (KD / WT ≥ 2). This increase in intron inclusion for genes in KD cells could also be observed in the raw RNA-seq data visualized in the UCSC genome browser ( Figure 5A ). Next we ascertained whether loss of CBX3 binding correlated with an increase in unspliced transcripts. We detected significant enrichment of CBX3 at genes with increased unspliced transcripts ( Figure 5B ). Analysis of a replicate RNA-seq data set produced similar results with significant overlap of genes found to have increased intronic inclusion (p-value <1x10 -16 ) and CBX3 enrichment ( Figure S6 ). Our data demonstrates that genes bound by CBX3 in WT cells display an increase in splicing defects upon depletion of CBX3. Of the 367 genes downregulated by the loss of CBX3 85 also have an increase in unspliced transcripts. It could be hypothesized that the decrease in transcript level is due to degradation of unspliced transcripts. However, the significant number of genes with either splicing defects or a decrease in transcript level but not both suggests that separate mechanisms of action could be at play.
CBX3 influences recruitment of splicing factors to actively transcribed genes
The spliceosome is a large multi-subunit complex that is assembled in a highly ordered and cooperative manner to the RNA transcript. SR (serine and arginine-rich)
proteins also bind to Ser2-phosphorylated RNA polymerase II and could play a role in recruiting splicing factors to the elongating polymerase (Lenasi and Barboric, 2010; Licatalosi and Darnell, 2010; Shepard and Hertel, 2009 Figure 6A ). This was not due to a decrease in the expression level of splicing factors in the KD cells, as the levels were comparable to those seen for WT HCT116 by western blot ( Figure S7A ).
Notably, this phenomenon was limited to active CBX3 bound genes where we observed splicing defects (e.g., IL1A) and not control, non-CBX3 targets, such as NFKB1 that do not have splicing defects ( Figure 6B ). Therefore, recruitment or stabilization of the spliceosome factors tested appears to be dependent upon CBX3 localization to the gene in question.
DISCUSSION
Heterochromatin protein 1 has been implicated in a diverse array of cellular processes including heterochromatin formation, gene silencing, DNA damage repair, telomere stability and RNAi mediated silencing (Dinant and Luijsterburg, 2009; Hediger and Gasser, 2006; Kwon and Workman, 2008; Zeng et al.) . Here, we provide evidence that in human cells CBX3 supports transcription and efficient splicing. We demonstrate that CBX3 is localized to the gene body of most actively transcribed genes. We observe that CBX3 preferentially associates with exons in multiple-exon genes. Knockdown of CBX3 expression results in downregulation of a subset of target genes and significant accumulation of unspliced transcripts from greater than 1000 transcripts. Depletion of CBX3 also causes a defect in recruitment of splicing factors SNRNP70 and SRSF1 to the CBX3 target gene IL1A. This is suggestive of a role for CBX3 in RNA processing through recruitment or stabilization of spliceosome components to at least a subset of target genes.
Heterochromatin protein 1 family proteins are conserved from yeast to humans, and are widely accepted as critical components of silenced/repressed chromatin (Dillon, 2004; Huisinga et al., 2006; Lomberk et al., 2006; Maison and Almouzni, 2004; Motamedi et al., 2008; Singh and Georgatos, 2002) . However, in Drosophila both Su(var)205 and HP1c are also found at active loci (de Wit et al., 2007; Fanti et al., 2003; Greil et al., 2003) . In mammalian cells, CBX5 and 1 are predominantly heterochromatic but are known to be recruited to specific promoters to silence transcription (Feldman et al., 2006; Yahi et al., 2008) . In contrast, CBX3 was found to be more widely associated with euchromatin and is recruited to silence promoters by a variety of factors (du Chene et al., 2007; Liu et al., 2010; Ogawa et al., 2002; Vicent et al., 2006) . More recently, CBX3 was also found localized to active genes in a number studies (Mateescu et al., 2008; Smallwood et al., 2007; Vakoc et al., 2005 expression for all but single-exon genes. The lack of requirement for CBX3 at singleexon genes strongly suggested a role for CBX3 in splicing. In support of this hypothesis, loss of CBX3 led to an increase in intron retention in CBX3 target transcripts.
Importantly, this is a genome wide phenomenon, and genes that exhibit splicing defects in the absence of CBX3 are bound by CBX3 in WT cells. Therefore, decreased transcript levels of CBX3 target genes observed upon CBX3 depletion in HCT116 cells may result from their increased degradation due to improper splicing or from a direct effect of CBX3 on transcriptional output.
Saint-Andre and colleagues suggest a role for CBX3 in alternative splicing of CD44 in HeLa cells, whereby depletion of CBX3 led to a decreased inclusion of variant exons. Our study takes a wider unbiased approach to determine the effect of CBX3 depletion on transcriptional and splicing processes genome wide. Therefore, in contrast to the previous study, we observed that loss of CBX3 caused a general increase in intron inclusion and loss of splicing and therefore resulted in accumulation of unspliced RNAs. However, GO analysis revealed that many of the unspliced transcripts that accumulate in KD cells are known to be alternatively spliced. It is therefore possible that CBX3 is playing multiple overlapping roles in splicing regulation.
It has been previously suggested in Drosophila that Su(var)205 could function to stabilize RNA transcripts (Piacentini et al., 2009 ). We performed RNA stability assays to determine if CBX3 affects splicing via RNA stabilization. HCT116 cells were treated with α-amanitin for 0-120 minutes and the RNA was isolated at various time points. Levels of HOXA9, EZR, and EHF spliced and un-spliced transcripts were determined by RT-qPCR using multiple independent primer sets ( Figure S7B, S7C, and S7D) . A decrease in splicing of these transcripts was observed in response to CBX3 knockdown in HCT116 cells. We could detect no difference in RNA stability between WT and KD cells therefore CBX3 must be functioning via a different mechanism in human cells.
Most notably, we demonstrated that in human cells depleted of CBX3, recruitment of the RNA splicing factors SNRNP70 and SRSF1 was decreased significantly to IL1A. This loss of splicing factor recruitment was specific to for CBX3 target genes. Levels of SNRNP70 and SRSF1 were unaffected at genes not bound by CBX3, such as NFKB1. While this data does not provide a direct role for CBX3 in splicing the correlation between CBX3 occupancy and splicing defects does implicate CBX3 in the process. RNA polymerase II plays a central role in the coupling of transcription and splicing Ser-2 of RNA polymerase II c-terminal domain (CTD) is phosphorylated during elongation, creating a binding platform for recruitment of splicing factors to the RNA template (Allemand et al., 2008; Tilgner and Guigo) . CBX3 also interacts with phosphorylated RNA polymerase II raising the possibility that the CTD of polymerase could act as a platform to coordinate the action of CBX3 and components of the splicing machinery. The splicing factor SRSF1 binds to Ser-2 phosphorylated RNAP II, and this interaction aids recruitment of U1 and U2 snRNPs (Allemand et al., 2008; Moore and Proudfoot, 2009; Perales and Bentley, 2009 ). We, and others, observe that CBX3 also associates with the elongating form of RNA polymerase II thus providing a mechanism by which CBX3 may influence the recruitment and/or activity of splicing factors.
Recently, Black and colleagues demonstrated that CBX3, along with a histone demethylase, plays a role in cell cycle regulation in C. elegans and human cells (Black et al., 2010) . Additionally, CBX3 has been implicated in controlling levels of primordial germ cells (PGCs) in mouse embryos via cell cycle regulation and apoptosis (Abe et al., 2011) . Overexpression of CBX3 has been detected in multiple cancer cell lines and is Cold Spring Harbor Laboratory Press on October 27, 2017 -Published by genome.cshlp.org Downloaded from thought to play a role in tumorigenesis (Takanashi et al., 2009 ). We performed GO term analysis of genes either downregulated or with decreased RNA processing upon depletion of CBX3. We determined that HP1γ is responsible for regulating many genes involved in cell cycle progression including; CDK11A, CDC25C, DDX11, ATM, and CCNE1. In addition, loss of CBX3 altered expression of PIM1, CAV2, and CCNE1 all of which are thought to be involved in cancer progression.
Collectively, this study extends the previous observation that CBX3 binds to gene bodies by demonstrating that this is a genome wide phenomenon. In addition, binding correlates with gene activity, in multiple cell types, and depletion of CBX3 leads to a decrease in transcription for a subset of target genes. Importantly, this study begins to shed light on another role of CBX3 in this context -aiding in efficient processing potentially via splicing factor recruitment. Our data provides evidence that CBX3 may play a role in a variety of cellular processes through regulation of gene expression and splicing.
Materials and methods.

Generation of stable CBX3 knockdown HCT116 cells
The CBX3 shRNA used in this study was designed using the pSicoOligomaker 1.5 algorithm (Jacks Lab, MIT). Oligonucleotides encoding the shRNA were annealed and cloned into the pLL3.7 lentiviral expression vector according to the Jacks Lab protocol.
Oligonucleotide sequences are as follows: Forward oligo: 5'-TGAGGCAGAGCCTGAAGAATTTCAAGAGAATTCTTCAGGCTCTGCCTCTTTTTTC-3';
Reverse oligo: 5'-TCGAGAAAAAAGAGGCAGAGCCTGAAGAATTCTC TTGAAATTCTTCAGGCTCTGCCTCA-3'. Lentivirus production and transduction of HCT116 cells were carried out using protocols established in the Jacks Lab. Individual HCT116 cell clones expressing the CBX3 shRNA were isolated by limiting dilution, and the degree of CBX3depletion in individual clones was ascertained by western blot analysis. Clones # 8 and #10 were selected for further study.
Cell Culture
K562, MDA-MB-231, and HCT116 cells were grown in Iscove's Modified Dulbecco's, Leibowitz, and McCoys media respectively, all supplemented with 10% FBS and 1% pen-strep. Cells were treated with either 10 ng/ml TNF for 30-60 mins or IFNG for 30 minutes. For ChIP, cells were crosslinked with 1% formaldehyde for 15 minutes at 37 o C then harvested as previously described (Kim et al., 2005b; Li et al., 2003) . For expression analysis, RNA was isolated with Trizol as per manufacturer's instructions.
Chromatin immunoprecipitation
ChIP was performed as previously described (Kim et al., 2005a; Li et al., 2003) . Briefly, 2 μg of specific antibodies were bound to Dynal magnetic secondary beads for 6 hours.
After washing, 200 μg of sonicated chromatin was incubated with the bead bound antibody overnight. Beads were washed and enriched DNA was isolated. ChIP DNA was then analyzed by hybridization to either custom made DNA microarrays covering the ENCODE regions (Kim et al., 2005a; Li et al., 2003) , or oligonucleotide microarray arrays covering the entire human genome (Roche Nimblegen) (Kim et al., 2005b) . The
ChIP DNA was also sequenced after adapter ligation and amplification steps as previously detailed. For qPCR analysis, samples and inputs were diluted
ChIP-chip analysis
Enriched DNA from ChIP experiments were prepped for hybridization to Roche Nimblegen microarrays as previously described (Kim et al., 2005b) . then dried. The arrays were scanned on an Axon GenePix 4000B scanner (Axon Instruments Inc.) at 532nm for Cy3 and 635nm for Cy5. We used MA2C package (Song et al., 2007) to do data normalization with default parameters (Robust C=2) and peak calling.
ChIP-Seq analysis
ChIP-Seq reads were mapped by the Eland to hg18, keeping only uniquely mapping genes and discarding all but one of clonal reads (number of monoclonal reads for each sample is included in Table S4 ). Blocks of CBX3 enrichment over input were identified as previously described (Hawkins et al, Cell Stem Cell, 2010) . 
GST-CBX3 purification
CBX3 protein and GST-CBX3 beads were purified as previously detailed (Smallwood et al., 2007; Vassallo and Tanese, 2002) . GST-CBX3 proteins were purified by expression in bacteria and enrichment on glutathione columns. Proteins were released from the GST tag and beads by thrombin cleavage. The concentration of CBX3 or GST-CBX3
was analyzed by SDS-page electrophoresis and coomassie staining.
Peptide Pulldowns
Interaction of soluble nuclear factors with immobilized peptides was performed as previously described (Sims et al., 2006; Wysocka et al., 2005) . In short, 5 μg of biotin tagged histone tail peptide was bound to 25 μl of streptavidin coated beads for 15 minutes at room temperature in 5 mM Tris pH 8.0, 0.5 mM EDTA, and 1M NaCl.
Unbound peptides were washed away by washing 3 times with 100 mM Buffer D. Beads were incubated with 300 ng -1 μg of purified HP1γ, in 300 μl of 100 mM Buffer D, for 2 hours at 4 o C. Unbound factors were removed by 3 washes with 300 mM Buffer D. CBX3 associated with the peptides was eluted by boiling in 2% SDS and analyzed by SDSpage electrophoresis and western blotting.
RT-qPCR
Total RNA was isolated by Trizol extraction, DNase 1 treated, then subjected to cDNA synthesis using Invitrogen Super script kit as per the manufacturer's instructions. qPCR analysis was performed using 0.5 μl of cDNA as template in 20 μl reaction volumes using Sybr green master mix from Roche. All results were normalized to GapDH expression. A no-RT control was included in each experiment to ensure results were not from contaminating DNA. Analysis shown is from at least 3 biological replicates for each sample run in triplicate on each qPCR plate, error bars correspond to the standard deviation of the biological replicates. p-values were calculated, by t-test, from the biological replicates. Specific primers used are listed in supplemental material.
RNA-seq
10 μg of total RNA was depleted of ribosomal RNA using the Invitrogen Ribominus kit.
The resulting RNA fraction was subjected to first strand cDNA synthesis using random primers in the presence of actinomycin D. Samples were cleaned up by applying reaction mix to mini G50 columns. The eluted sample was then subjected to second strand synthesis with DNA polymerase I, DNA ligase, and dUNTPs in the presence of RNase H. This ensures that the cDNA strand complementary to the mRNA has dNTPs and that the other strand is specifically labeled with dUNTPs. The cDNA was purified by QIA-quick-QG columns then sonicated using a Bioruptor and fragment size assessed by mini-gel electrophoresis. The fragmented cDNA was subsequently end repaired, A-tailed and then ligated to adapters. After Qiagen column purification the samples were size selected on a 2% high-resolution agarose gel. Fragments corresponding to 175-350 bps were excised from the gel and collected by Qiagen column purification. The fragments were then treated with UDGase to remove the labeled strand and then the mRNA complementary cDNA strand was amplified by PCR and subjected to sequencing analysis using the Illumina GAII. Reads were mapped by bowtie to hg18, keeping only uniquely mapping genes and discarding all but one of clonal reads. RPKM was calculated as the number of reads per kilo base of exon model per million reads mapped.
Data Access
Sequencing data is available under the GEO accession number: GSE28115. 
